| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.65 | 0.02 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |